全球神經血管導管市場規模、佔有率、成長分析，依應用（栓塞性中風、腦動脈瘤）、依類型（微型、球囊）- 2024-2031 年產業預測

Global Neurovascular Catheters Market Size, Share, Growth Analysis, By Application(Embolic Stroke, Brain Aneurysms), By Type(Micro, Balloon) - Industry Forecast 2024-2031

出版日期: 2024年04月08日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球神經血管導管市場規模為30.3億美元，預計將從2023年的32.5億美元成長到2031年的56.6億美元，預測期間（2024-2031年）複合年成長率為7.20%。

幾個重要的促進因素推動了神經血管市場的發展，包括腦動脈瘤和中風等神經系統疾病的發生率不斷上升、不健康生活方式的養成、公眾對神經系統疾病治療的意識增強、可支配收入的增加以及主要市場參與者推出新產品。神經血管疾病的激增以及神經血管導管技術的進步將推動市場擴張。值得注意的是，全球蜘蛛網膜下腔出血（SAH）盛行率為每10萬人有6.67人，每年影響超過50萬人，其中低收入和中等收入國家承受沉重負擔。此外，由於神經血管通路導管的技術突破，市場預計將持續成長。例如，2022年2月，強生醫療器材公司子公司CERENOVUS推出了EMBOGUARD，這是一種用於血管內手術（包括急性缺血性中風介入）的尖端球囊導引導管。隨著對不同神經血管通路導管的持續研究和比較研究，市場可能會進一步擴大，例如2022 年9 月的研究強調了內徑為0.096 英吋的通路導管對於透過股動脈和橈動脈進行神經血管治療的功效，證明了技術成功率高，手術併發症極少。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 歐洲其他地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 拉丁美洲其他地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- MEA 的其餘部分

競爭格局

前 5 名企業比較
2021 年關鍵參與者的市場定位
主要市場參與者所採取的策略
最佳制勝策略
近期市集活動
主要公司市佔率（%），2021年

主要公司簡介

Medtronic plc (Ireland)
Stryker Corporation (US)
Terumo Corporation (Japan)
Penumbra, Inc. (US)
MicroPort Scientific Corporation (China)
Johnson & Johnson (US)
Merit Medical Systems, Inc. (US)
Integer Holdings Corporation (US)
Teleflex Incorporated (US)
Penumbra, Inc. (US)
Rapid Medical Ltd. (Israel)
MicroVention, Inc. (US)
Acandis GmbH (Germany)
Balt Extrusion (France)
Covidien (US)
Boston Scientific Corporation (US)
Cook Medical LLC (US)
Phenox GmbH (Germany)
Stryker Neurovascular (US)
Balt USA LLC (US)
Metactive Medical, Inc. (US)
Amplitude Surgical SA (France)

簡介目錄

Product Code: SQMIG35A2523

Global Neurovascular Catheters Market size was valued at USD 3.03 Billion in 2022 and is poised to grow from USD 3.25 Billion in 2023 to USD 5.66 Billion by 2031, at a CAGR of 7.20% during the forecast period (2024-2031).

Several significant drivers propel the neurovascular market, including the escalating incidence of neurological disorders like brain aneurysms and stroke, the uptake of unhealthy lifestyles, heightened public consciousness regarding neurological ailment treatment, increasing disposable income, and the introduction of novel products by major market players. The surge in neurovascular diseases alongside advancements in neurovascular catheter technology are poised to fuel market expansion. Notably, the global prevalence of subarachnoid hemorrhage (SAH) stands at 6.67 per 100,000 individuals, affecting over 500,000 people annually, with low- and middle-income countries bearing a substantial burden. Furthermore, market growth is expected to persist due to technological breakthroughs in neurovascular access catheters. For instance, in February 2022, CERENOVUS, a subsidiary of Johnson & Johnson Medical Device Companies, launched EMBOGUARD, a cutting-edge balloon guide catheter for endovascular procedures, including acute ischemic stroke interventions. The market is likely to expand further with ongoing research and comparative studies on different neurovascular access catheters, such as the study in September 2022 highlighting the efficacy of access catheters with an inner diameter of 0.096 inches for neurovascular therapies via both femoral and radial arteries, demonstrating high technical success rates and minimal procedural complications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neurovascular Catheters Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Neurovascular Catheters Market Segmental Analysis

Global Neurovascular Catheters Market is segmented on the basis of application, type, end use and region. By type, the market is segmented into micro, balloon, access, embolization, and others. By application, the market is segmented into embolic stroke, brain aneurysms, arteriovenous malformations, and others. By end use, the market is segmented into hospitals, clinics, ambulatory surgical centers, and diagnostic centers. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Neurovascular Catheters Market

The increasing incidence of neurological conditions like stroke, aneurysms, and arteriovenous malformations (AVMs) is fueling the need for neurovascular catheters, which are crucial for both diagnosis and treatment. As the occurrence of these disorders continues to rise, the demand for neurovascular catheters is also escalating accordingly.

Restraints in the Global Neurovascular Catheters Market

Neurovascular catheters are employed for accessing and maneuvering through intricate blood vessels within the brain, presenting challenges that may result in diverse complications including bleeding, clotting, vessel perforation, and infection. These complications pose significant risks, potentially leading to severe neurological impairments or fatality, and contribute to prolonged hospitalization and escalated healthcare expenses. Furthermore, the likelihood of complications is heightened in patients with concurrent medical conditions.

Market Trends of the Global Neurovascular Catheters Market

The rising occurrence of neurological conditions like stroke, aneurysms, and arteriovenous malformations is fueling the need for neurovascular catheters. As per the World Health Organization (WHO), stroke ranks as the second most prevalent cause of death worldwide, intensifying the demand for viable treatment solutions for neurological disorders.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Neurovascular Catheters Market by Application

Market Overview
Embolic Stroke
Brain Aneurysms
Arteriovenous Malformations
Others

Global Neurovascular Catheters Market by Type

Market Overview
Micro
Balloon
Access
Embolization
Others

Global Neurovascular Catheters Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penumbra, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merit Medical Systems, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integer Holdings Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teleflex Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penumbra, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Rapid Medical Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroVention, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Acandis GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Balt Extrusion (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Covidien (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Phenox GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Neurovascular (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Balt USA LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Metactive Medical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amplitude Surgical SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments